Correlation Between Pharmacom Biovet and IMAC Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmacom Biovet and IMAC Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmacom Biovet and IMAC Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmacom Biovet and IMAC Holdings, you can compare the effects of market volatilities on Pharmacom Biovet and IMAC Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmacom Biovet with a short position of IMAC Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmacom Biovet and IMAC Holdings.

Diversification Opportunities for Pharmacom Biovet and IMAC Holdings

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pharmacom and IMAC is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmacom Biovet and IMAC Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IMAC Holdings and Pharmacom Biovet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmacom Biovet are associated (or correlated) with IMAC Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IMAC Holdings has no effect on the direction of Pharmacom Biovet i.e., Pharmacom Biovet and IMAC Holdings go up and down completely randomly.

Pair Corralation between Pharmacom Biovet and IMAC Holdings

If you would invest  375.00  in IMAC Holdings on October 29, 2024 and sell it today you would lose (302.00) from holding IMAC Holdings or give up 80.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pharmacom Biovet  vs.  IMAC Holdings

 Performance 
       Timeline  
Pharmacom Biovet 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmacom Biovet has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Pharmacom Biovet is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
IMAC Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IMAC Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pharmacom Biovet and IMAC Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmacom Biovet and IMAC Holdings

The main advantage of trading using opposite Pharmacom Biovet and IMAC Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmacom Biovet position performs unexpectedly, IMAC Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IMAC Holdings will offset losses from the drop in IMAC Holdings' long position.
The idea behind Pharmacom Biovet and IMAC Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments